CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
84 hedge funds and large institutions have $707M invested in Crescent Biopharma, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 23 closing their positions.
Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
33
Reduced
16
Closed
23
Calls
$6.31M
Puts
$2.07M
Net Calls
+$4.24M
Net Calls Change
+$6.06M
Top Buyers
| 1 |
O
1
OppenheimerFunds
New York
|
$40.7M |
| 2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$93.9M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$27.5M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$46.6M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$18.9M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
SG Americas Securities
New York
| – | – | -6,156 | Closed |
|
102
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -933 | Closed |
|
103
CIBC Private Wealth Group
Atlanta,
Georgia
| – | – | -800 | Closed |
|
|
PO
104
Private Ocean
San Rafael,
California
| – | – | -500 | Closed |
|
|
RFM
105
Royal Fund Management
Lady Lake,
Florida
| – | – | -412 | Closed |
|
|
MAM
106
Meeder Asset Management
Dublin,
Ohio
| – | – | -54 | Closed |
|
|
CHP
107
Cable Hill Partners
Portland,
Oregon
| – | – | -10 | -100% |
|
108
JPMorgan Chase & Co
New York
| – | – | – | – |
|